167 related articles for article (PubMed ID: 23742090)
1. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach.
Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM
Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090
[TBL] [Abstract][Full Text] [Related]
2. Effect of oxidative stress on the production of recombinant human interferon-gamma in Escherichia coli.
Mohammadian-Mosaabadi J; Naderi-Manesh H; Maghsoudi N; Khalilzadeh R; Shojaosadati SA; Ebrahimi M
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):37-42. PubMed ID: 15030320
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli.
Yan X; Hu S; Guan YX; Yao SJ
Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693
[TBL] [Abstract][Full Text] [Related]
4. On-column refolding of recombinant human interferon-gamma with an immobilized chaperone fragment.
Gao YG; Guan YX; Yao SJ; Cho MG
Biotechnol Prog; 2003; 19(3):915-20. PubMed ID: 12790657
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and identification of recombinant human interferon-gamma].
Wu D; Gao D; Bai Q; Geng X
Se Pu; 2008 Mar; 26(2):206-11. PubMed ID: 18581854
[TBL] [Abstract][Full Text] [Related]
6. [Cloning, expression and purification of interferon-kappa, a novel human interferon, and its antiviral activity].
Zhang H; Duan ZJ; Zhu JG; Peng FW; Li WP; Gao HC; Xie ZP; Wang YE; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):223-6. PubMed ID: 16261202
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and characterization of human interferon-γ in Pichia pastoris.
Wang D; Ren H; Xu JW; Sun PD; Fang XD
Mol Med Rep; 2014 Feb; 9(2):715-9. PubMed ID: 24253448
[TBL] [Abstract][Full Text] [Related]
8. Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics.
Li J; Li B; Zhang J; Hou L; Yu C; Fu L; Song X; Yu T; Zhang J; Ren J; Xu C; Chen W
Antiviral Res; 2011 Mar; 89(3):199-203. PubMed ID: 21277904
[TBL] [Abstract][Full Text] [Related]
9. Production, purification and characterization of recombinant human interferon gamma.
Zhang Z; Tong KT; Belew M; Pettersson T; Janson JC
J Chromatogr; 1992 Jun; 604(1):143-55. PubMed ID: 1639923
[TBL] [Abstract][Full Text] [Related]
10. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
[TBL] [Abstract][Full Text] [Related]
11. [Soluble expression of chicken interferon-gamma and antiviral activity of purified expression product].
Qi J; Du Y; Zhu X; Hu B; Sun S; Zhang X; Liu Y
Wei Sheng Wu Xue Bao; 2009 Jan; 49(1):85-91. PubMed ID: 19388269
[TBL] [Abstract][Full Text] [Related]
12. [Expression of porcine interferon-gamma and its safe antiviral assay].
He F; Sun Y; Ge J; Li M; Chang T; Bu Z; Qiu H
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):439-47. PubMed ID: 20575430
[TBL] [Abstract][Full Text] [Related]
13. Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography.
Reddy PK; Reddy SG; Narala VR; Majee SS; Konda S; Gunwar S; Reddy RC
Protein Expr Purif; 2007 Mar; 52(1):123-30. PubMed ID: 17049266
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheres.
Yang J; Cleland JL
J Pharm Sci; 1997 Aug; 86(8):908-14. PubMed ID: 9269868
[TBL] [Abstract][Full Text] [Related]
15. Chromatographic refolding of recombinant human interferon gamma by an immobilized sht GroEL191-345 column.
Guan YX; Fei ZZ; Luo M; Jin T; Yao SJ
J Chromatogr A; 2006 Feb; 1107(1-2):192-7. PubMed ID: 16427063
[TBL] [Abstract][Full Text] [Related]
16. Stability of recombinant bovine interferon-γ antiviral activity in the absence of stabilizing additives.
Xu Q; Nomura T; Ikeda M; Ohta M; Kameyama K; Konishi M; Wu D; Inumaru S; Murakami K
Microbiol Immunol; 2011 Aug; 55(8):595-8. PubMed ID: 21545512
[TBL] [Abstract][Full Text] [Related]
17. [Biological activities of recombinant human interferon Epsilon].
Peng FW; Gao HC; Xie ZP; Zhang H; Li QM; Duan ZJ; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):227-31. PubMed ID: 16261203
[TBL] [Abstract][Full Text] [Related]
18. An approach for increasing the mass recovery of proteins derived from inclusion bodies in biotechnology.
Wu D; Wang C; Geng X
Biotechnol Prog; 2007; 23(2):407-12. PubMed ID: 17373822
[TBL] [Abstract][Full Text] [Related]
19. Glucose-methanol-based fed-batch fermentation for the production of recombinant human interferon gamma (rhIFN-γ) and evaluation of its antitumor potential.
Prabhu AA; Kumar JP; Mandal BB; Veeranki VD
Biotechnol Appl Biochem; 2020 Nov; 67(6):973-982. PubMed ID: 31811672
[TBL] [Abstract][Full Text] [Related]
20. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
Petrov S; Nacheva G; Ivanov I
Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
